EMBASSY ACQUISITION 8-K 5/6/97

Company

Protalix BioTherapeutics, Inc.

Filed

May 6, 1997

Period of Report

May 6, 1997

Accession Number

0000950144-97-005148

An 8-K is a current report used to announce material events that shareholders should know about — such as earnings releases, mergers, executive changes, or bankruptcy. Learn more about 8-K filings →